General Mills shareholders reject proposal to dump GM foods

gmcheer

General Mills Inc. has made strong commitments this year to natural and organic foods. It took genetically modified ingredients out of its signature cereal brand Cheerios and then doubled down on its organic lineup by striking an $820-million deal for Annie’s, a stalwart of the organic and natural foods industry.

But when the industrial food behemoth’s shareholders were presented with a proposal to dump all genetically modified ingredients from the company’s vast lineup of brands, they responded with a resounding “No.”

The rejection of the proposal also shows shareholders aren’t convinced it’s unsafe to consume genetically modified organisms, better known as GMOs, which are created in labs by altering plant genes. This is often done to resist disease and pests. Though there is no definitive science showing such plants are harmful to human health, it has become one of the most contentious issues in modern food policy. Critics say the effect of widespread genetically modified crops may not be felt for years.

“We’ve studied all the research that’s been done around the world, we are very aware of the numerous regulators globally who have studied GMOs and who have said they are safe,” said General Mills Chief Executive Ken Powell, according to the Pioneer Press. “And of course we know and believe GMOs are very safe.”

Read full, original article: General Mills shareholders reject proposal to dump GMOs

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-27-2026-11_47_30-AM-2
FDA’s expedited drug reviews are hailed in some quarters but other approval practices are problematic
Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
Farmers can talk to plants
Farmers are a major source of misinformation—about farming
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challenging 
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
Screenshot 2026-05-06 at 2.19
Vaccine shootout at the CDC 
What explains Homo sapiens’ huge brains? Ancient climate change played a role
Viewpoint: Internal White House documents detail administration’s strategy to undermine climate science
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint — Food-fear world: The latest activist scientists campaign: Cancer-causing additives
ChatGPT-Image-May-7-2026-11_28_04-AM-2
‘Conflict entrepreneurs’ are driving disinformation and shaping public opinion
ChatGPT-Image-May-6-2026-03_41_05-PM
‘Protecting the integrity of science’: Kennedy’s FDA blocks release of taxpayer-funded studies finding COVID and shingles vaccines safe
Screenshot-2026-05-06-at-2.07.43-PM
Manufacturing a conspiracy: The timeline of how  the White House embraced the fringe claim that scientists are being mysteriously murdered
bigstock opioids on chalkboard with rol
GLP podcast: 'Safe injection sites': enabling drug addiction or saving lives?
Screenshot 2026-05-06 at 2.56
Singularity crisis ahead? Can super babies save us from rogue AI geniuses?
circular-bioeconomy-should-focus-on-sustainable-wellbeing
GLP podcast: What's wrong with 'doomsday' environmentalism? It's false.
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.